|
CN106327986A
|
|
Manufacturing method for early embryo presentation model of mouse
|
|
CN106234362A
|
|
Ascarid glycoside △ C9 application in Monochamus alternatus preventing and treating and obstruction Bursaphelenchus xylophilus are propagated
|
|
CN106234361A
|
|
Ascarid glycoside △ C7 application in Monochamus alternatus preventing and treating and obstruction Bursaphelenchus xylophilus are propagated
|
|
CN106234363A
|
|
Ascarid glycoside △ C8 application in Monochamus alternatus preventing and treating and obstruction Bursaphelenchus xylophilus are propagated
|
|
CN106172405A
|
|
Ascarid glycoside C7 application in Monochamus alternatus preventing and treating and obstruction Bursaphelenchus xylophilus are propagated
|
|
CN106342808A
|
|
Application of ascaroside C9 in prevention and control of monochamus alternates and intercepting of spreading of pine wood nematode
|
|
CN106172406A
|
|
Ascarid glycoside C8 application in Monochamus alternatus preventing and treating and obstruction Bursaphelenchus xylophilus are propagated
|
|
CN106096612A
|
|
Trypetid image identification system and method
|
|
CN105838676A
|
|
Culture solution for retinal pigment epitheliums and preparation method and application thereof
|
|
CN105797147A
|
|
CXCL13 (chemokine(C-X-C motif) ligand 13) DNA vaccine and application thereof
|
|
CN105727295A
|
|
Medical use of Wip1 inhibitor
|
|
CN105648113A
|
|
Plasmid reference molecule for quantitatively detecting PxGV (plutella xylostella granulovirus) and application of plasmid reference molecule
|
|
CN105519588A
|
|
Disinfectant, and preparation method and application thereof
|
